REC Interventional Cardiology English Ed最新文献

筛选
英文 中文
Left atrial appendage occlusion vs oral anticoagulants in atrial fibrillation and coronary stenting. The DESAFIO registry 心房颤动和冠状动脉支架置入术中左心耳闭塞与口服抗凝剂的比较。DESAFIO注册表
REC Interventional Cardiology English Ed Pub Date : 2023-07-10 DOI: 10.24875/recice.m23000386
J. López-Mínguez, E. Suárez-Corchuelo, S. López-Tejero, L. Nombela‐Franco, X. Freixa-Rofastes, G. Bastos-Fernandez, X. Millán-Álvarez, R. Moreno-Gómez, J. Fernandez-Diaz, I. Amat-Santos, T. Benito-González, F. Alfonso-Manterola, P. Salinas-Sanguino, P. Cepas-Guillen, D. Arzamendi, I. Cruz-González, and Juan Manuel Nogales-Asensio
{"title":"Left atrial appendage occlusion vs oral anticoagulants in atrial fibrillation and coronary stenting. The DESAFIO registry","authors":"J. López-Mínguez, E. Suárez-Corchuelo, S. López-Tejero, L. Nombela‐Franco, X. Freixa-Rofastes, G. Bastos-Fernandez, X. Millán-Álvarez, R. Moreno-Gómez, J. Fernandez-Diaz, I. Amat-Santos, T. Benito-González, F. Alfonso-Manterola, P. Salinas-Sanguino, P. Cepas-Guillen, D. Arzamendi, I. Cruz-González, and Juan Manuel Nogales-Asensio","doi":"10.24875/recice.m23000386","DOIUrl":"https://doi.org/10.24875/recice.m23000386","url":null,"abstract":"Introduction and objectives: The treatment of patients with non-valvular atrial fibrillation (NVAF) who need coronary stenting is challenging. The objective of the study was to determine whether left atrial appendage occlusion (LAAO) could be a feasible option and benefit these patients. To this end, we studied the impact of LAAO plus antiplatelet drugs vs oral anticoagulants (OAC) (including direct OAC) plus antiplatelet drugs in these patients’ long-term outcomes . Methods: The results of 207 consecutive patients with NVAF who underwent coronary stenting were analyzed. A total of 146 patients were treated with OAC (75 with acenocoumarol, 71 with direct OAC) while 61 underwent LAAO. The median follow-up was 35 months. Patients also received antiplatelet therapy as prescribed by their cardiologist. The study received the proper ethical oversight. Results: Age (mean 75.7 years), and the past medical history of stroke were similar in both groups. However, the LAAO group had more unfavorable characteristics (history of coronary artery disease [CHA 2 DS 2 -VASc], and significant bleeding [BARC ≥ 2] and HAS-BLED). The occurrence of major adverse events (death, stroke/transient ischemic events, major bleeding) and major cardiovascular events (cardiac death, stroke/transient ischemic attack, and myocardial infarction) were significantly higher in the OAC group compared to the LAAO group: 19.75% vs 9.06% (HR, 2.18; P = .008) and 6.37% vs 1.91% (HR, 3.34; P = .037), respectively. Conclusions: In patients with NVAF undergoing coronary stenting, LAAO plus antiplatelet therapy produced better long-term outcomes compared to treatment with OAC plus antiplatelet therapy despite the unfavorable baseline characteristics of the LAAO group.","PeriodicalId":34613,"journal":{"name":"REC Interventional Cardiology English Ed","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44528678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Atrial flow regulator and atrial septostomy in pediatric pulmonary hypertension: when procedure and device match 心房流量调节剂和房间隔造口术治疗小儿肺动脉高压:当手术和设备匹配时
REC Interventional Cardiology English Ed Pub Date : 2023-07-05 DOI: 10.24875/recice.m23000391
Lisa Bianco, A. Sabaté-Rotés, A. Torrent‐Vernetta, and Pedro Betrián-Blasco
{"title":"Atrial flow regulator and atrial septostomy in pediatric pulmonary hypertension: when procedure and device match","authors":"Lisa Bianco, A. Sabaté-Rotés, A. Torrent‐Vernetta, and Pedro Betrián-Blasco","doi":"10.24875/recice.m23000391","DOIUrl":"https://doi.org/10.24875/recice.m23000391","url":null,"abstract":"a Unidad de Hemodinámica Pediátrica, Hospital Vall d’Hebrón, Universitat Autònoma de Barcelona, Barcelona, Spain b Servicio de Cardiología Pediátrica, Hospital Vall d’ Hebrón, Universitat Autònoma de Barcelona, Barcelona, Spain c Servicio de Alergia Pediátrica, Neumología Pediátrica y Fibrosis Quística, Hospital Vall d’ Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain d Centro de Investigación en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Spain Scientific letter","PeriodicalId":34613,"journal":{"name":"REC Interventional Cardiology English Ed","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48493177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coronary malperfusion in acute type A aortic dissection 急性A型主动脉夹层冠状动脉灌注不良
REC Interventional Cardiology English Ed Pub Date : 2023-06-29 DOI: 10.24875/recice.m23000392
Cristina Morante Perea, Tomás Cantón Rubio, Luis Manuel Hernando Romero, J. B. Buendía Miñano, J. Moreu Burgos, and Luis Rodríguez Padial
{"title":"Coronary malperfusion in acute type A aortic dissection","authors":"Cristina Morante Perea, Tomás Cantón Rubio, Luis Manuel Hernando Romero, J. B. Buendía Miñano, J. Moreu Burgos, and Luis Rodríguez Padial","doi":"10.24875/recice.m23000392","DOIUrl":"https://doi.org/10.24875/recice.m23000392","url":null,"abstract":", Coronary malperfusion in patients with aortic dissection further worsens prognosis due to compromised myocardial blood flow. The incidence rate of coronary disease goes from 9% to 10% according to various registries. 1,2 Also, it can occur simultaneously at the beginning of dissection, during the patient transfer or in the middle of surgery. The management of these patients is still a matter of discussion. The optimal time of myocardial reperfusion is 90 min, a timeframe that cannot be guaranteed with surgical revascularization associated with aortic valve repair surgery. This is the case of a 65-year-old man. The patient was a smoker with chronic kidney disease who was admitted to our center as a «myocar-dial infarction code» case due to suspected anterior ST-segment elevation acute coronary syndrome. The coronary angiography revealed the presence of a type A aortic dissection with coronary malperfusion due to left main coronary artery (LMCA) occlusion. The patient had reported to his tertiary referral center with a 30-min history of oppressive retrosternal chest pain. Upon arrival at the emergency room, he remained symptomatic and hemody-namically unstable (pale, sweaty,","PeriodicalId":34613,"journal":{"name":"REC Interventional Cardiology English Ed","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41746576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Doctor, I want a TAVI! Should patients choose the type of aortic valve procedure they want? 医生,我想要一个TAVI!患者应该选择他们想要的主动脉瓣手术类型吗?
REC Interventional Cardiology English Ed Pub Date : 2023-06-29 DOI: 10.24875/recice.m23000396
M. Martínez‐Sellés
{"title":"Doctor, I want a TAVI! Should patients choose the type of aortic valve procedure they want?","authors":"M. Martínez‐Sellés","doi":"10.24875/recice.m23000396","DOIUrl":"https://doi.org/10.24875/recice.m23000396","url":null,"abstract":"","PeriodicalId":34613,"journal":{"name":"REC Interventional Cardiology English Ed","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47264998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Debate. Cerebral embolic protection systems in TAVI: there is not enough evidence available 辩论TAVI的脑栓塞保护系统:没有足够的证据
REC Interventional Cardiology English Ed Pub Date : 2023-06-21 DOI: 10.24875/recice.m23000384
Pedro Luis Martín Lorenzo
{"title":"Debate. Cerebral embolic protection systems in TAVI: there is not enough evidence available","authors":"Pedro Luis Martín Lorenzo","doi":"10.24875/recice.m23000384","DOIUrl":"https://doi.org/10.24875/recice.m23000384","url":null,"abstract":",","PeriodicalId":34613,"journal":{"name":"REC Interventional Cardiology English Ed","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49326574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Debate. Cerebral embolic protection systems in TAVI: there is some supportive evidence 辩论TAVI的脑栓塞保护系统:有一些支持性证据
REC Interventional Cardiology English Ed Pub Date : 2023-06-21 DOI: 10.24875/recice.m23000374
P. Jiménez Quevedo
{"title":"Debate. Cerebral embolic protection systems in TAVI: there is some supportive evidence","authors":"P. Jiménez Quevedo","doi":"10.24875/recice.m23000374","DOIUrl":"https://doi.org/10.24875/recice.m23000374","url":null,"abstract":"Answer: Former studies described that, during TAVI, loose debris like arterial wall fragments, thrombi, valve tissue, and foreign bodies often enters the circulation.1 These particles are the aftermath of the device making its way through the aorta towards the aortic annulus, the positioning and displacement of a calcified stenotic valve between the new valve stent and the aortic wall, and further manipulations to optimize results (postdilatation). To this date, numerous studies have been published on the safety and efficacy profile of these cerebral protection devices (CPD). Specifically, 4 randomized clinical trials have been published associated with the SENTINEL (Boston Scientific Corp., United States): MISTRAL-C,2 CLEAN TAVI,3 SENTINEL,4 and PROTECTED TAVR5 we can talk about later on. The MISTRAL-C trial used cerebral magnetic resonance imaging to demonstrate a significant reduction in the number of patients with multiple cerebral lesions (20% vs 0%; P = .03) and less cognitive impairment (4% vs 27%; P = .017). Similarly, the CLEAN TAVI trial also reported fewer novel lesions and of a smaller volume without any differences being reported in the number of clinical events in the group that used CPD. These studies demonstrated fragments being captured in almost in 100% of the cases. Several metanalyses6-13 also confirm these results regarding the number and volume of cerebral lesions described, and even some show lower rates of strokes in the DPC group.10,12,13 Therefore, we not only have the visual in situ demonstration of the particles being captured in the baskets following implantation, but also scientific evidence that CPD are effective capturing fragments released during TAVI that can land in cerebral circulation, thus lowering the number of cerebral lesions found on the magnetic resonance imaging during the procedure. However, whether capturing such particles with the device has a clear clinical benefit for its widespread use is still to be elucidated.","PeriodicalId":34613,"journal":{"name":"REC Interventional Cardiology English Ed","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45984924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Provoked exercise desaturation in patients with patent foramen ovale, infrequent or underdiagnosed? 卵圆孔未闭患者的诱发性运动去饱和:罕见还是未确诊?
REC Interventional Cardiology English Ed Pub Date : 2023-06-21 DOI: 10.24875/recice.m23000388
V. Juárez Olmos, O. Gonzalez-Fernandez, Alfonso Jurado Román, S. Jiménez Valero, C. Contreras Lorenzo, and Almudena Castro Conde
{"title":"Provoked exercise desaturation in patients with patent foramen ovale, infrequent or underdiagnosed?","authors":"V. Juárez Olmos, O. Gonzalez-Fernandez, Alfonso Jurado Román, S. Jiménez Valero, C. Contreras Lorenzo, and Almudena Castro Conde","doi":"10.24875/recice.m23000388","DOIUrl":"https://doi.org/10.24875/recice.m23000388","url":null,"abstract":"The patent oval foramen (PFO) is present in nearly 1 out of every 4 people","PeriodicalId":34613,"journal":{"name":"REC Interventional Cardiology English Ed","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47437113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transfemoral valve-in-MAC implantation due to severe radiation-induced mitral stenosis 严重放射性二尖瓣狭窄MAC植入术中的经股瓣膜
REC Interventional Cardiology English Ed Pub Date : 2023-06-20 DOI: 10.24875/recice.m23000377
M. Maeztu, L. Ruiz, Leire Andraka, M. Larman, G. Lasa, and Jesús Roberto Sáez
{"title":"Transfemoral valve-in-MAC implantation due to severe radiation-induced mitral stenosis","authors":"M. Maeztu, L. Ruiz, Leire Andraka, M. Larman, G. Lasa, and Jesús Roberto Sáez","doi":"10.24875/recice.m23000377","DOIUrl":"https://doi.org/10.24875/recice.m23000377","url":null,"abstract":"","PeriodicalId":34613,"journal":{"name":"REC Interventional Cardiology English Ed","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49080163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The MANTA Vascular Closure Device in transfemoral TAVI: a real-world cohort. MANTA血管闭合装置在经股TAVI中的应用:一个真实世界的队列
REC Interventional Cardiology English Ed Pub Date : 2023-06-09 eCollection Date: 2024-01-01 DOI: 10.24875/RECICE.M23000380
Sofia Martinho, Elisabete Jorge, Vera Marinho, Rui Baptista, Marco Costa, Lino Gonçalves
{"title":"The MANTA Vascular Closure Device in transfemoral TAVI: a real-world cohort.","authors":"Sofia Martinho, Elisabete Jorge, Vera Marinho, Rui Baptista, Marco Costa, Lino Gonçalves","doi":"10.24875/RECICE.M23000380","DOIUrl":"10.24875/RECICE.M23000380","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>Transcatheter aortic valve implantation (TAVI) is an established treatment option for patients with symptomatic severe aortic stenosis often performed via transfemoral access route (TF-TAVI). Therefore, successful closure of large-bore access sites is essential. This study aims to investigate the safety and effectiveness of the MANTA (Teleflex/Essential Medical, United States) vascular closure device (VCD) in patients undergoing TF-TAVI in an unselected and consecutive cohort of patients.</p><p><strong>Methods: </strong>We conducted a single-center, observational study of 245 consecutive patients undergoing TF-TAVI in whom the arterial large-bore femoral access was closed with a MANTA device from March 2020 through February 2022. The primary efficacy outcome measure was the rate of VCD failure according to the VARC-3 definition.</p><p><strong>Results: </strong>Successful closure of the large-bore access site occurred in 92.2% of the patients (n = 226). According to the VARC-3 definition, no major vascular or bleeding complications related to the plug-based VCD were reported. Patients with failed VCDs (7.8%) had significantly smaller minimal femoral artery diameters (6.6 ± 1.1 mm vs 7.6 ± 1.4 mm; <i>P</i> = .005) and consequently, significant higher sheath-to-femoral artery diameter ratios (0.78 ± 0.16 vs 0.69 ± 0.15; <i>P</i> = .019). No other inter-group differences were found.</p><p><strong>Conclusions: </strong>In this single-center, real-world, unselected large cohort of consecutive patients treated with TF-TAVI, a plug-based VCD for large-bore arteriotomy closure turned out effective and safe, and enabled arterial access-site management with a low rate of complications.</p>","PeriodicalId":34613,"journal":{"name":"REC Interventional Cardiology English Ed","volume":" ","pages":"7-12"},"PeriodicalIF":0.0,"publicationDate":"2023-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12097317/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42463556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of ischemic preconditioning on the radial artery vasomotor function 缺血预处理对桡动脉血管舒缩功能的影响
REC Interventional Cardiology English Ed Pub Date : 2023-06-08 DOI: 10.24875/recice.m23000382
E. Arroyo-Úcar, B. Ibáñez Cabeza, and Gonzalo Pizarro Sánchez
{"title":"Impact of ischemic preconditioning on the radial artery vasomotor function","authors":"E. Arroyo-Úcar, B. Ibáñez Cabeza, and Gonzalo Pizarro Sánchez","doi":"10.24875/recice.m23000382","DOIUrl":"https://doi.org/10.24875/recice.m23000382","url":null,"abstract":"","PeriodicalId":34613,"journal":{"name":"REC Interventional Cardiology English Ed","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43948379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书